KYNTRA BIO, INC. Research and Development Expense
KYNTRA BIO, INC. (KYNB) reported Research and Development Expense of $6.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-13
- KYNTRA BIO, INC. research and development expense for the quarter ending 2026-06-30 was $6.82M, a 16.30% increase year-over-year.
- KYNTRA BIO, INC. research and development expense for the quarter ending 2026-03-31 was $7.57M, a 17.54% decline year-over-year.
- KYNTRA BIO, INC. research and development expense for the quarter ending 2025-12-31 was $7.27M, a 5.82% increase year-over-year.
- KYNTRA BIO, INC. research and development expense for the quarter ending 2025-09-30 was $1.21M, a 93.95% decline year-over-year.
- KYNTRA BIO, INC. research and development expense for fiscal 2025 was $23.52M, a 75.42% decline from fiscal 2024.
- KYNTRA BIO, INC. research and development expense for fiscal 2024 was $95.69M, a 64.09% decline from fiscal 2023.
- KYNTRA BIO, INC. research and development expense for fiscal 2023 was $266.47M, a 10.22% decline from fiscal 2022.
- KYNTRA BIO, INC. research and development expense for fiscal 2022 was $296.79M, a 23.32% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.82M 10-Q · filed 2026-08-13 | $14.39M 10-Q · filed 2026-08-13 | $21.66M derived: sum of 3 quarters · filed 2026-08-13 | $22.86M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $7.57M 10-Q · filed 2026-05-12 | $14.83M derived: sum of 2 quarters · filed 2026-05-12 | $16.04M derived: sum of 3 quarters · filed 2026-05-12 | $21.91M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $7.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $8.48M derived: sum of 2 quarters · filed 2026-03-16 | $14.34M derived: sum of 3 quarters · filed 2026-08-13 | $23.52M 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | $1.21M 10-Q · filed 2025-11-10 | $7.07M derived: sum of 2 quarters · filed 2026-08-13 | $16.25M 10-Q · filed 2025-11-10 | $23.12M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $5.87M 10-Q · filed 2026-08-13 | $15.04M 10-Q · filed 2026-08-13 | $21.91M derived: sum of 3 quarters · filed 2026-08-13 | $41.88M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $9.18M 10-Q · filed 2026-05-12 | $16.04M derived: sum of 2 quarters · filed 2026-05-12 | $36.02M derived: sum of 3 quarters · filed 2026-05-12 | $68.38M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $6.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $26.84M derived: sum of 2 quarters · filed 2026-03-16 | $59.20M derived: sum of 3 quarters · filed 2026-03-16 | $95.69M 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | $19.97M 10-Q · filed 2025-11-10 | $21.71M 10-Q · filed 2024-11-12 | $52.33M derived: sum of 2 quarters · filed 2025-11-10 | $88.82M 10-Q · filed 2025-11-10 | $94.21M 10-Q · filed 2024-11-12 | $124.14M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $32.36M 10-Q · filed 2025-08-11 | $34.11M 10-Q · filed 2024-08-06 | $68.85M 10-Q · filed 2025-08-11 | $72.50M 10-Q · filed 2024-08-06 | $104.16M derived: sum of 3 quarters · filed 2025-08-11 | $165.36M derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $36.49M 10-Q · filed 2025-05-12 | $38.39M 10-Q · filed 2024-05-06 | $71.80M derived: sum of 2 quarters · filed 2025-05-12 | $133.00M derived: sum of 3 quarters · filed 2025-05-12 | $228.48M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | $35.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $96.51M derived: sum of 2 quarters · filed 2025-03-17 | $191.99M derived: sum of 3 quarters · filed 2025-03-17 | $266.47M 10-K · filed 2025-03-17 | $282.86M 10-K · filed 2024-02-26 | |||
| 2023-09-30 | $61.19M 10-Q · filed 2024-11-12 | $156.67M derived: sum of 2 quarters · filed 2024-11-12 | $231.16M 10-Q · filed 2024-11-12 | $292.79M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $95.48M 10-Q · filed 2024-08-06 | $169.96M 10-Q · filed 2024-08-06 | $231.59M derived: sum of 3 quarters · filed 2024-08-06 | $306.77M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $74.49M 10-Q · filed 2024-05-06 | $136.11M derived: sum of 2 quarters · filed 2024-05-06 | $211.30M derived: sum of 3 quarters · filed 2024-05-06 | $282.26M derived: sum of 4 quarters · filed 2024-05-06 | ||||
| 2022-12-31 | $61.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $136.81M derived: sum of 2 quarters · filed 2024-02-26 | $207.77M derived: sum of 3 quarters · filed 2024-02-26 | $296.79M 10-K · filed 2024-02-26 | ||||
| 2022-09-30 | $75.18M 10-Q · filed 2023-11-06 | $146.15M derived: sum of 2 quarters · filed 2023-11-06 | $235.16M 10-Q · filed 2023-11-06 | $349.08M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-06-30 | $70.96M 10-Q · filed 2023-08-07 | $159.98M 10-Q · filed 2023-08-07 | $273.90M derived: sum of 3 quarters · filed 2024-02-26 | $349.78M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2022-03-31 | $89.02M 10-Q · filed 2023-05-08 | $202.94M derived: sum of 2 quarters · filed 2024-02-26 | $278.82M derived: sum of 3 quarters · filed 2024-02-26 | $401.38M derived: sum of 4 quarters · filed 2024-02-26 | ||||
| 2021-12-31 | $113.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $189.80M derived: sum of 2 quarters · filed 2024-02-26 | $312.37M derived: sum of 3 quarters · filed 2024-02-26 | $387.04M 10-K · filed 2024-02-26 | ||||
| 2021-09-30 | $75.88M 10-Q · filed 2022-11-07 | $198.45M derived: sum of 2 quarters · filed 2022-11-07 | $273.12M 10-Q · filed 2022-11-07 | $351.25M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | $122.57M 10-Q · filed 2022-08-08 | $197.24M 10-Q · filed 2022-08-08 | $275.38M derived: sum of 3 quarters · filed 2023-02-27 | $333.85M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | $74.68M 10-Q · filed 2022-05-09 | $152.81M derived: sum of 2 quarters · filed 2023-02-27 | $211.28M derived: sum of 3 quarters · filed 2023-02-27 | $272.70M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $78.13M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $136.61M derived: sum of 2 quarters · filed 2023-02-27 | $198.02M derived: sum of 3 quarters · filed 2023-02-27 | $252.92M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | $58.48M 10-Q · filed 2021-11-09 | $119.89M derived: sum of 2 quarters · filed 2021-11-09 | $174.79M 10-Q · filed 2021-11-09 | $231.59M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2020-06-30 | $61.41M 10-Q · filed 2021-08-09 | $116.31M 10-Q · filed 2021-08-09 | $173.11M derived: sum of 3 quarters · filed 2022-03-04 | $223.08M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2020-03-31 | $54.90M 10-Q · filed 2021-05-10 | $111.70M derived: sum of 2 quarters · filed 2022-03-04 | $161.66M derived: sum of 3 quarters · filed 2022-03-04 | $213.67M derived: sum of 4 quarters · filed 2022-03-04 | ||||
| 2019-12-31 | $56.80M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-04 | $106.76M derived: sum of 2 quarters · filed 2022-03-04 | $158.77M derived: sum of 3 quarters · filed 2022-03-04 | $209.26M 10-K/A · filed 2022-03-04 | ||||
| 2019-09-30 | $49.96M 10-Q · filed 2020-11-05 | $101.97M derived: sum of 2 quarters · filed 2020-11-05 | $152.47M 10-Q · filed 2020-11-05 | $222.75M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $52.01M 10-Q · filed 2020-08-06 | $102.50M 10-Q · filed 2020-08-06 | $172.79M derived: sum of 3 quarters · filed 2021-03-01 | $229.23M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $50.50M 10-Q · filed 2020-05-07 | $120.78M derived: sum of 2 quarters · filed 2021-03-01 | $177.22M derived: sum of 3 quarters · filed 2021-03-01 | $229.36M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $70.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $126.73M derived: sum of 2 quarters · filed 2021-03-01 | $178.87M derived: sum of 3 quarters · filed 2021-03-01 | $235.84M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $56.44M 10-Q · filed 2019-11-12 | $108.58M derived: sum of 2 quarters · filed 2019-11-12 | $165.56M 10-Q · filed 2019-11-12 | $218.02M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-06-30 | $52.14M 10-Q · filed 2019-08-08 | $109.11M 10-Q · filed 2019-08-08 | $161.58M derived: sum of 3 quarters · filed 2020-03-02 | $211.92M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2018-03-31 | $56.97M 10-Q · filed 2019-05-09 | $109.44M derived: sum of 2 quarters · filed 2020-03-02 | $159.78M derived: sum of 3 quarters · filed 2020-03-02 | $206.76M derived: sum of 4 quarters · filed 2020-03-02 | ||||
| 2017-12-31 | $52.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $102.80M derived: sum of 2 quarters · filed 2020-03-02 | $149.78M derived: sum of 3 quarters · filed 2020-03-02 | $196.52M 10-K · filed 2020-03-02 | ||||
| 2017-09-30 | $50.34M 10-Q · filed 2018-11-08 | $97.32M derived: sum of 2 quarters · filed 2018-11-08 | $144.05M 10-Q · filed 2018-11-08 | $194.66M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-06-30 | $46.98M 10-Q · filed 2018-08-07 | $93.71M 10-Q · filed 2018-08-07 | $144.32M derived: sum of 3 quarters · filed 2019-02-27 | $184.88M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2017-03-31 | $46.73M 10-Q · filed 2018-05-09 | $97.34M derived: sum of 2 quarters · filed 2019-02-27 | $137.90M derived: sum of 3 quarters · filed 2019-02-27 | $190.29M derived: sum of 4 quarters · filed 2019-02-27 | ||||
| 2016-12-31 | $50.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $91.17M derived: sum of 2 quarters · filed 2019-02-27 | $143.56M derived: sum of 3 quarters · filed 2019-02-27 | $187.21M 10-K · filed 2019-02-27 | ||||
| 2016-09-30 | $40.56M 10-Q · filed 2017-11-08 | $92.95M derived: sum of 2 quarters · filed 2017-11-08 | $136.60M 10-Q · filed 2017-11-08 | $196.52M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $52.39M 10-Q · filed 2017-08-07 | $96.04M 10-Q · filed 2017-08-07 | $155.97M derived: sum of 3 quarters · filed 2018-02-27 | $208.04M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $43.65M 10-Q · filed 2017-05-09 | $103.57M derived: sum of 2 quarters · filed 2018-02-27 | $155.65M derived: sum of 3 quarters · filed 2018-02-27 | $207.20M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $59.92M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $112.00M derived: sum of 2 quarters · filed 2018-02-27 | $163.55M derived: sum of 3 quarters · filed 2018-02-27 | $214.09M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $52.07M 10-Q · filed 2016-11-08 | $103.63M derived: sum of 2 quarters · filed 2016-11-08 | $154.16M 10-Q · filed 2016-11-08 | $205.42M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $51.55M 10-Q · filed 2016-08-08 | $102.09M 10-Q · filed 2016-08-08 | $153.35M derived: sum of 3 quarters · filed 2017-03-01 | $193.97M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $50.54M 10-Q · filed 2016-05-09 | $101.80M derived: sum of 2 quarters · filed 2017-03-01 | $142.41M derived: sum of 3 quarters · filed 2017-03-01 | $175.68M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $51.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $91.88M derived: sum of 2 quarters · filed 2017-03-01 | $125.14M derived: sum of 3 quarters · filed 2017-03-01 | $150.79M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $40.62M 10-Q · filed 2015-11-12 | $73.89M derived: sum of 2 quarters · filed 2015-11-12 | $99.54M 10-Q · filed 2015-11-12 | |||||
| 2014-06-30 | $33.27M 10-Q · filed 2015-08-13 | $58.92M 10-Q · filed 2015-08-13 | ||||||
| 2014-03-31 | $25.65M 10-Q · filed 2015-05-12 | |||||||
| 2013-12-31 | $85.71M 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |